U.S. Markets close in 15 mins

Johnson & Johnson beats Q1 earnings, despite 14% profit loss

UBS Biotechnology Analyst Carter Gould breaks it down to Yahoo Finance's Julie Hyman, Adam Shapiro, and BMO Capital Markets Chief Investment Strategist Brian Belski.